CS logo
small CS logo
Universitaetsspital Basel; Onkologie

Basel, Switzerland

About Universitaetsspital Basel; Onkologie


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Universitaetsspital Basel; Onkologie


During the past decade, Universitaetsspital Basel; Onkologie conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 7 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Universitaetsspital Basel; Onkologie" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Foundation Medicine, Inc." with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at Universitaetsspital Basel; Onkologie


According to Clinical.Site data, the most researched conditions in "Universitaetsspital Basel; Onkologie" are "Non-Small Cell Lung Cancer" (4 trials), "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Advanced Solid Tumors" (1 trials) and "Cancer of Unknown Primary Site" (1 trials). Many other conditions were trialed in "Universitaetsspital Basel; Onkologie" in a lesser frequency.

Clinical Trials Intervention Types at Universitaetsspital Basel; Onkologie


Most popular intervention types in "Universitaetsspital Basel; Onkologie" are "Drug" (13 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (6 trials), "Carboplatin" (3 trials), "Paclitaxel" (3 trials), "Alectinib" (2 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Universitaetsspital Basel; Onkologie


The vast majority of trials in "Universitaetsspital Basel; Onkologie" are 13 trials for "All" genders.

Clinical Trials Status at Universitaetsspital Basel; Onkologie


Currently, there are NaN active trials in "Universitaetsspital Basel; Onkologie". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Universitaetsspital Basel; Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Universitaetsspital Basel; Onkologie, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".